Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PROCEPT BioRobotics (PRCT) Share-based Compensation (2020 - 2025)

PROCEPT BioRobotics has reported Share-based Compensation over the past 6 years, most recently at $10.8 million for Q4 2025.

  • Quarterly results put Share-based Compensation at $10.8 million for Q4 2025, up 19.34% from a year ago — trailing twelve months through Dec 2025 was $47.6 million (up 49.51% YoY), and the annual figure for FY2025 was $47.6 million, up 49.51%.
  • Share-based Compensation for Q4 2025 was $10.8 million at PROCEPT BioRobotics, down from $14.5 million in the prior quarter.
  • Over the last five years, Share-based Compensation for PRCT hit a ceiling of $14.5 million in Q3 2025 and a floor of $650000.0 in Q1 2021.
  • Median Share-based Compensation over the past 5 years was $5.0 million (2023), compared with a mean of $5.6 million.
  • Biggest five-year swings in Share-based Compensation: soared 269.1% in 2022 and later grew 19.34% in 2025.
  • PROCEPT BioRobotics' Share-based Compensation stood at $1.5 million in 2021, then soared by 92.85% to $2.9 million in 2022, then soared by 72.65% to $5.0 million in 2023, then soared by 82.39% to $9.1 million in 2024, then increased by 19.34% to $10.8 million in 2025.
  • The last three reported values for Share-based Compensation were $10.8 million (Q4 2025), $14.5 million (Q3 2025), and $12.2 million (Q2 2025) per Business Quant data.